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End-Stage Lung Disease
This edition of Operative Techniques in Thoracic and Cardio-
ascular Surgery includes 2 superb articles on the surgical
management of end-stage lung diseases. In the first article,
Dr. Marc de Perrot describes his approach to performing
pulmonary thromboendarterectomy for the management of
chronic thromboembolic pulmonary hypertension. This is an
underappreciated technique by thoracic surgeons and Dr. de
Perrot describes the technique clearly; the text is supported
by helpful illustrations. Although much of the success in
managing these patients depends on patient selection, a
thoughtful, well-conceived, and expertly performed opera-
tion is mandatory for these patients to do well. In the com-
panion article, Drs. Walter Klepetko and Aigner describe
their approach to performing a double lung transplant. Dr.
Klepetko is one of the world’s leading authorities on lung
transplantation and his article on the technical aspects of the
procedure is a wonderful addition to the literature. Both of
these operations, pulmonary thromboendarterectomy and
lung transplantation, are formidable procedures, but if per-
formed as described by the authors, the outcomes can be
excellent.
Replace or Repair?
Techniques for Management
of Ischemic Mitral Regurgitation
The Cardiac Surgery topic is ischemic mitral regurgitation.
Controversy exists regarding whether repair or replacement
is the preferred modality in patients with ischemic mitral
regurgitation. Previous investigations have demonstrated the
benefit of preserving the integrity of the mitral apparatus,
should replacement be the chosen modality. Dr. David pres-
ents an elegant description of chordal-sparing mitral valve
replacement. He also demonstrates a technique for chordal
replacement, should it be necessary to resect some or all of
the chords, to preserve the continuity of the subvalvular ap-
paratus. As there is general agreement that ischemic mitral
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pair techniques that do not address the ventricular compo-
nent of this disease have been less than satisfactory. Kron has
developed a technique of papillary muscle relocation as a
method of improving leaflet coaptation and the durability of
mitral valve repair in ischemic mitral regurgitation. The arti-
cle by LaPar and Kron clearly depicts the critical steps in this
operation.
Tetralogy of Fallot
with Complete Common
Atrioventricular Canal Defect
The incidence of tetralogy of Fallot among patients with com-
plete common atrioventricular defect is estimated to be about
6% to 10%. This defect is classified as an endocardial cushion
defect with anterior deviation of the conal (infundibular) sep-
tum. The net result is a common atrioventricular valve, pri-
mum atrial septal defect inlet “canal” ventricular septal de-
fect, and right ventricular outflow tract (RVOT) obstruction.
As a result, physiology may range from a “balanced” circula-
tion with a Qp/Qs of 1:1 to that of insufficient pulmonary
blood flow, depending on the degree of RVOT obstruction.
This combination of lesions poses certain unique structural
and physiological challenges to the surgeon. There remains
considerable controversy regarding the timing of surgery: (1)
initial palliative systemic to pulmonary artery shunt vs com-
plete repair; (2) the use of a single patch vs multiple patches
to address the septal defects; and (3) the surgical approach to
relieve RVOT obstruction and the need for performing a
transannular patch. In the Congenital Surgery section of this
issue, experts advocating either the single patch or the
2-patch technique describe their methods for repair of tetral-
ogy of Fallot with atrioventricular canal defect. There is par-
ticular focus on closure of the ventricular septal defect and
repair of the common atrioventricular valve. The modifica-
tions described by these experts have the potential to im-
prove outcomes for these complex infants.
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